Document is current
Any future updates will be listed below
-
Authors
Kuipers, Maria T.
Migchelbrink, Jorne
Kramer, Anne Marijn
Kouwenhoven, Mathilde C. M.
Zweegman, Sonja
Groen, Kaz
van de Donk, Niels W. C. J. https://orcid.org/0009-0007-1251-4649
- License Information
-
More Information
Article History
Accepted: 26 April 2026
First Online: 15 May 2026
Declarations
:
: N.W.C.J.v.d.D. has received research support from Janssen Pharmaceuticals, AMGEN, Celgene, CellCentric, Novartis, Cellectis and BMS, and serves on advisory boards for Janssen Pharmaceuticals, AMGEN, Celgene, BMS, Sanofi, Takeda, Roche, Novartis, Bayer, Adaptive, Galapagos, Kite Pharma, Merck, Pfizer, AbbVie, and Servier, all paid to institution. S.Z. has received research funding from Takeda and Janssen, and serves on advisory boards for Janssen, Takeda, and BMS, all paid to institution. M.T.K., J.M., A.M.K., M.C.M.K., and K.G. have no conflicts of interest that might be relevant to the contents of this manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: No datasets were generated or analyzed during the current study.
: Not applicable.
: All authors contributed equally to the writing of this review.
